- Home
- KYMR vs NOVT Comparison
KYMR vs NOVT Comparison
Compare KYMR & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYMR | NOVT |
|---|---|---|
| Founded | 2015 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Industrial Machinery/Components |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 3.8B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KYMR | NOVT |
|---|---|---|
| Price | $81.32 | $122.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 23 | 1 |
| Target Price | $105.35 | ★ $133.00 |
| AVG Volume (30 Days) | ★ 1.4M | 411.9K |
| Earning Date | 11-04-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.46 |
| Revenue | $43,735,000.00 | ★ $960,311,000.00 |
| Revenue This Year | $18.71 | $5.10 |
| Revenue Next Year | N/A | $6.75 |
| P/E Ratio | ★ N/A | $84.05 |
| Revenue Growth | N/A | ★ 4.07 |
| 52 Week Low | $19.45 | $98.27 |
| 52 Week High | $103.00 | $157.11 |
Technical Indicators
Market Signals| Indicator | KYMR | NOVT |
|---|---|---|
| Relative Strength Index (RSI) | 56.53 | 57.08 |
| Support Level | $82.55 | $118.42 |
| Resistance Level | $85.41 | $129.50 |
| Average True Range (ATR) | 5.10 | 3.72 |
| MACD | -0.75 | 0.49 |
| Stochastic Oscillator | 14.43 | 55.13 |
Price Performance
Historical ComparisonAbout KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About NOVT Novanta Inc.
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.